GlassScriptPhysician profile
Sujatha D Pathi
NPI 1639353279
$5,891.96
in general payments reported to CMS, 2019-2025
14 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,194 · 2020: $29.19 · 2021: $93.64 · 2022: $168 · 2023: $2,767 · 2024: $366 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,928 · Food and Beverage: $1,450 · Gift: $28.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,927.97 |
| Food and Beverage | $1,450.35 |
| Gift | $28.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,515.52 | 2021-2023 | Axonics |
| Intuitive Surgical, INC. | $2,143.72 | 2019 | |
| Sumitomo Pharma America, INC. | $715.09 | 2023-2025 | Gemtesa |
| Urovant Sciences INC | $154.66 | 2021-2022 | |
| Allergan, INC. | $81.52 | 2019-2022 | |
| Hologic Sales and Service, LLC | $72.91 | 2024 | Myosure Tissue Removal Device |
| Abbvie INC. | $61.30 | 2023-2024 | |
| Astellas Pharma US INC | $48.66 | 2022-2024 | Veozah |
| Caldera Medical, INC | $28.88 | 2023 | Desara |
| Medtronic USA, INC. | $17.86 | 2019 | |
| Therapeuticsmd, INC. | $16.15 | 2020 | |
| Boston Scientific Corporation | $15.32 | 2022 | |
| Teleflex LLC | $13.04 | 2020 | |
| Mayne Pharma Commercial LLC | $7.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sujatha Pathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.